Drug-话题@MedSci

#Drug#

153篇内容 | 3697人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1862311, encodeId=48a61862311a0, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!, objectType=article, longId=139583, objectId=d4b01395839b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4b01395839b, replyNumber=0, likeNumber=105, createdTime=2019-01-12, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4b01395839b, moduleTitle=Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4b01395839b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862294, encodeId=9f0e186229478, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Safety:哪些降压药物会增加恶性黑色素瘤的发生风险？, objectType=article, longId=124977, objectId=43c11249e770, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c11249e770, replyNumber=0, likeNumber=66, createdTime=2018-09-14, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c11249e770, moduleTitle=Drug Safety:哪些降压药物会增加恶性黑色素瘤的发生风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43c11249e770)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862296, encodeId=e688186229699, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Curr Cancer Drug Targets：在人类前列腺癌中，SOCS6通过诱导细胞凋亡和抑制血管生成起肿瘤抑制子的作用, objectType=article, longId=126453, objectId=cd76126453b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd76126453b7, replyNumber=0, likeNumber=73, createdTime=2018-11-22, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd76126453b7, moduleTitle=Curr Cancer Drug Targets：在人类前列腺癌中，SOCS6通过诱导细胞凋亡和抑制血管生成起肿瘤抑制子的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd76126453b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862304, encodeId=013d18623048d, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Safety：PPI使用与痴呆风险之间的相关性或被高估, objectType=article, longId=133157, objectId=15d413315ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15d413315ee7, replyNumber=0, likeNumber=55, createdTime=2018-08-18, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15d413315ee7, moduleTitle=Drug Safety：PPI使用与痴呆风险之间的相关性或被高估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15d413315ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862306, encodeId=68a218623062c, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Deliv：深圳先进院开发出治疗胎盘绒毛膜癌靶向纳米载药系统, objectType=article, longId=134206, objectId=1b06134206c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b06134206c1, replyNumber=0, likeNumber=79, createdTime=2018-12-15, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b06134206c1, moduleTitle=Drug Deliv：深圳先进院开发出治疗胎盘绒毛膜癌靶向纳米载药系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b06134206c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862323, encodeId=976118623239b, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Des Devel Ther：全反式维甲酸可拮抗不同BMP诱导的成骨细胞生成, objectType=article, longId=152592, objectId=dc3315259224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc3315259224, replyNumber=0, likeNumber=71, createdTime=2018-11-24, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc3315259224, moduleTitle=Drug Des Devel Ther：全反式维甲酸可拮抗不同BMP诱导的成骨细胞生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc3315259224)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862313, encodeId=02ae186231317, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Geno Med：PanDrugs——根据个体基因组特征优化肿瘤治疗的新方法, objectType=article, longId=143245, objectId=101b143245df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=101b143245df, replyNumber=0, likeNumber=77, createdTime=2019-03-12, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=101b143245df, moduleTitle=Geno Med：PanDrugs——根据个体基因组特征优化肿瘤治疗的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=101b143245df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862295, encodeId=3d461862295db, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？, objectType=article, longId=125575, objectId=84211255e562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84211255e562, replyNumber=0, likeNumber=104, createdTime=2018-09-30, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84211255e562, moduleTitle=CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84211255e562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862287, encodeId=fcd9186228ede, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？, objectType=article, longId=118573, objectId=89291185e355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89291185e355, replyNumber=0, likeNumber=67, createdTime=2018-04-16, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89291185e355, moduleTitle=Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89291185e355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862290, encodeId=9b9a186229063, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：未成年人抗抑郁药超说明书使用的程度和风险, objectType=article, longId=120814, objectId=2ab1120814c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab1120814c5, replyNumber=0, likeNumber=80, createdTime=2018-08-31, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab1120814c5, moduleTitle=Pharmacoepidemiol Drug Saf：未成年人抗抑郁药超说明书使用的程度和风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab1120814c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862316, encodeId=2d0e1862316a4, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Deliv：原位紫外交联脂质强化水凝胶局部释放吉西他滨可有效抑制骨肉瘤, objectType=article, longId=148549, objectId=849114854902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849114854902, replyNumber=0, likeNumber=102, createdTime=2019-05-18, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849114854902, moduleTitle=Drug Deliv：原位紫外交联脂质强化水凝胶局部释放吉西他滨可有效抑制骨肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=849114854902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862285, encodeId=5d6e18622850c, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：为规避糖尿病风险不使用他汀并非明智之选, objectType=article, longId=118571, objectId=b3d81185e177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d81185e177, replyNumber=0, likeNumber=56, createdTime=2018-02-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d81185e177, moduleTitle=Pharmacoepidemiol Drug Saf：为规避糖尿病风险不使用他汀并非明智之选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d81185e177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862303, encodeId=90221862303ab, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Nat Rev Drug Discov：激酶抑制剂药物路在何方？, objectType=article, longId=133132, objectId=ca02133132ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca02133132ba, replyNumber=0, likeNumber=59, createdTime=2019-02-27, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca02133132ba, moduleTitle=Nat Rev Drug Discov：激酶抑制剂药物路在何方？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca02133132ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862288, encodeId=1cd018622884b, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：肝素诱导性血小板减少症：血栓栓塞并发症的风险因素是什么？, objectType=article, longId=118582, objectId=f2dd118582ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2dd118582ae, replyNumber=0, likeNumber=74, createdTime=2018-03-02, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2dd118582ae, moduleTitle=Pharmacoepidemiol Drug Saf：肝素诱导性血小板减少症：血栓栓塞并发症的风险因素是什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2dd118582ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862298, encodeId=5c8d18622982b, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=CNS Drugs：帕金森病患者心血管自主神经功能障碍的药物治疗, objectType=article, longId=126992, objectId=103b12699230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=103b12699230, replyNumber=0, likeNumber=91, createdTime=2018-12-27, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=103b12699230, moduleTitle=CNS Drugs：帕金森病患者心血管自主神经功能障碍的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=103b12699230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862312, encodeId=9b0b18623124f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药, objectType=article, longId=142550, objectId=cc031425500b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc031425500b, replyNumber=0, likeNumber=64, createdTime=2018-09-08, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc031425500b, moduleTitle=CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc031425500b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862299, encodeId=6e871862299d6, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=NAT REV DRUG DISCOV：CAR-T疗法全球市场分析, objectType=article, longId=129765, objectId=fa35129e65c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa35129e65c0, replyNumber=0, likeNumber=58, createdTime=2018-02-27, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa35129e65c0, moduleTitle=NAT REV DRUG DISCOV：CAR-T疗法全球市场分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa35129e65c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862305, encodeId=f13b18623052f, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Drug Safety:钙通道阻滞剂或增加肺癌风险, objectType=article, longId=133158, objectId=9f541331581f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f541331581f, replyNumber=0, likeNumber=60, createdTime=2018-07-03, rootId=0, userName=wangbingxhy, userId=baf586, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f541331581f, moduleTitle=Drug Safety:钙通道阻滞剂或增加肺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f541331581f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862289, encodeId=09a51862289dc, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：ACEI/ARB相关的血管性水肿也有种族“歧视”？, objectType=article, longId=118584, objectId=c21b118584ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c21b118584ac, replyNumber=0, likeNumber=62, createdTime=2018-01-31, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c21b118584ac, moduleTitle=Pharmacoepidemiol Drug Saf：ACEI/ARB相关的血管性水肿也有种族“歧视”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c21b118584ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862271, encodeId=9f7f18622e101, content=<a href='/topic/show?id=1f0e626267' target=_blank style='color:#2F92EE;'>#Drug#</a>, objectTitle=Pharmacoepidemiol Drug Saf：药物非特异性不良事件的类型、频率和负担, objectType=article, longId=108544, objectId=a18c1085442d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18c1085442d, replyNumber=0, likeNumber=70, createdTime=2017-09-18, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18c1085442d, moduleTitle=Pharmacoepidemiol Drug Saf：药物非特异性不良事件的类型、频率和负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18c1085442d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Drug

2020-05-29

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Nat Rev Drug Discov：全新细胞疗法全景图,6个月增长87%、375项临床研究、753种癌症细胞疗法!

2019-01-12

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Drug Safety:哪些降压药物会增加恶性黑色素瘤的发生风险？

2018-09-14

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Curr Cancer Drug Targets：在人类前列腺癌中，SOCS6通过诱导细胞凋亡和抑制血管生成起肿瘤抑制子的作用

2018-11-22

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Drug Safety：PPI使用与痴呆风险之间的相关性或被高估

2018-08-18

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Drug Deliv：深圳先进院开发出治疗胎盘绒毛膜癌靶向纳米载药系统

2018-12-15

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Drug Des Devel Ther：全反式维甲酸可拮抗不同BMP诱导的成骨细胞生成

2018-11-24

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Geno Med：PanDrugs——根据个体基因组特征优化肿瘤治疗的新方法

2019-03-12

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？

2018-09-30

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：患过敏疾病的儿童使用H1-抗组胺药安全吗？

2018-04-16

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：未成年人抗抑郁药超说明书使用的程度和风险

2018-08-31

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Drug Deliv：原位紫外交联脂质强化水凝胶局部释放吉西他滨可有效抑制骨肉瘤

2019-05-18

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：为规避糖尿病风险不使用他汀并非明智之选

2018-02-01

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Nat Rev Drug Discov：激酶抑制剂药物路在何方？

2019-02-27

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：肝素诱导性血小板减少症：血栓栓塞并发症的风险因素是什么？

2018-03-02

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

CNS Drugs：帕金森病患者心血管自主神经功能障碍的药物治疗

2018-12-27

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药

2018-09-08

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

NAT REV DRUG DISCOV：CAR-T疗法全球市场分析

2018-02-27

wangbingxhy (审核中...)

前往app查看评论内容

#Drug#

Drug Safety:钙通道阻滞剂或增加肺癌风险

2018-07-03

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：ACEI/ARB相关的血管性水肿也有种族“歧视”？

2018-01-31

爆笑小医 (审核中...)

前往app查看评论内容

#Drug#

Pharmacoepidemiol Drug Saf：药物非特异性不良事件的类型、频率和负担

2017-09-18

科室
- - 订阅+
  - 更多科室
工具
服务